CClinicalTrials.gg
Not yet recruitingNCT07535892Updated Jun 26, 2026

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

An interventional study of Weight Loss Maintenance Program (Foundational) and Mom's Meals in Weight Loss, GLP - 1 and Weight Loss Maintenance, sponsored by University of Alabama at Birmingham. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a single-site, pilot randomized factorial trial designed to evaluate the feasibility, acceptability, participant perceptions and preliminary effects of a multi-component behavioral intervention to support weight loss maintenance following discontinuation of GLP-1 and other anti-obesity medications. The intervention includes a standardized 10-week foundational weight loss maintenance program combined with candidate support components, including medically tailored meals, YMCA membership, and a structured mind-based program. Participants will be randomized using a 2 × 2 × 2 factorial design and followed for six months. Findings from this pilot study will inform optimization of a scalable intervention for future clinical trials.

02

Conditions studied

  • Weight Loss
  • GLP - 1
  • Weight Loss Maintenance
  • Obesity & Overweight

Keywords

  • Weight Loss
  • GLP-1
  • Anti-Obesity Medication
  • weight loss maintenance
03

In context

Weight Loss

1,766 studies on the registry are indexed under Weight Loss; 277 are open to participants now.

This study's planned enrollment of 64 is below the median of 73 across 1,496 interventional studies indexed under Weight Loss.

Browse Weight Loss studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 years or older
  • Loss of ≥15% of initial body weight using anti-obesity medication
  • Discontinued anti-obesity medication within the past 4 weeks or planning to discontinue prior to randomization
  • ≤3 kg weight regain within the past 3 months
  • Willing and able to participate in a 6-month behavioral intervention, including a 10-week foundational program
  • Willing to complete study assessments at baseline, 3 months, and 6 months, including required in-person visits
  • Medical clearance for participation in moderate physical activity, dietary modification, and mind-based practices
  • Access to reliable internet for participation in virtual sessions and remote data collection
  • English fluency sufficient to complete study procedures
  • Able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Medical conditions that would preclude safe participation in physical activity, dietary changes, or mind-based practices (e.g., unstable cardiovascular disease, uncontrolled hypertension, severe orthopedic limitations, or seizure disorders not medically managed)
  • Active psychiatric conditions that would interfere with participation or safety (e.g., untreated major depression, active substance use disorder, or psychosis)
  • Pregnancy, breastfeeding, or plans to become pregnant during the study period
  • Current participation in another structured weight loss or weight maintenance program
  • Continued use of anti-obesity medication after randomization
  • Plans to initiate medications or treatments that may significantly affect body weight during the study period
  • Inability to attend required study visits or participate in virtual sessions and remote data collection
  • Any condition that, in the opinion of the investigators, would compromise participant safety or study integrity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Active comparator
    Group 1: WLM Program + Mom's Meals + YMCA + SKY

    Eight participants will be assigned to the foundational WLM program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive three candidate support components: (1) medically tailored meals (Mom's Meals), (2) YMCA membership to support physical activity, and (3) the SKY Meditation program to support mind-based practices.

    Behavioral: Weight Loss Maintenance Program (Foundational) · Behavioral: Mom's Meals · Behavioral: YMCA Membership · Behavioral: SKY Meditation Program

  • Active comparator
    Group 2: WLM Program + Mom's Meals + YMCA

    Eight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive two candidate support components: (1) medically tailored meals (Mom's Meals), (2) YMCA membership to support physical activity.

    Behavioral: Weight Loss Maintenance Program (Foundational) · Behavioral: Mom's Meals · Behavioral: YMCA Membership

  • Active comparator
    Group 3: WLM Program + Mom's Meals + SKY

    Eight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive candidate support components: (1) medically tailored meals (Mom's Meals), and (3) the SKY Meditation program to support mind-based practices.

    Behavioral: Weight Loss Maintenance Program (Foundational) · Behavioral: Mom's Meals · Behavioral: SKY Meditation Program

  • Active comparator
    Group 4: WLM Program + Mom's Meals

    Eight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive candidate support components: (1) medically tailored meals (Mom's Meals).

    Behavioral: Weight Loss Maintenance Program (Foundational) · Behavioral: Mom's Meals

  • Active comparator
    Group 5: WLM Program + YMCA + SKY

    Eight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive candidate support components: (2) YMCA membership to support physical activity, and (3) the SKY Meditation program to support mind-based practices.

    Behavioral: Weight Loss Maintenance Program (Foundational) · Behavioral: YMCA Membership · Behavioral: SKY Meditation Program

  • Active comparator
    Group 6: WLM Program + YMCA

    Eight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive support components: (2) YMCA membership to support physical activity.

    Behavioral: Weight Loss Maintenance Program (Foundational) · Behavioral: YMCA Membership

  • Active comparator
    Group 7: WLM Program + SKY

    Eight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive support components: (3) the SKY Meditation program to support mind-based practices.

    Behavioral: Weight Loss Maintenance Program (Foundational) · Behavioral: SKY Meditation Program

  • Active comparator
    Group 8: Foundational WLM Program Only

    Eight participants will receive the 10-week foundational program. One group (n=8) will receive only the foundational program without any additional components.

    Behavioral: Weight Loss Maintenance Program (Foundational)

Interventions

  • BehavioralWeight Loss Maintenance Program (Foundational)

    All participants will receive a standardized 10-week foundational weight loss maintenance program designed to address three key domains: food, physical activity, and mind-based practices. This foundational program is intended to support the transition from active weight loss to long-term weight maintenance.

  • BehavioralMom's Meals

    Medically tailored meals

  • BehavioralYMCA Membership

    YMCA membership to support physical activity

  • BehavioralSKY Meditation Program

    The SKY Meditation program to support mind-based practices

06

What researchers measure

Primary outcomes

  1. Percentage of participants retention

    Retention will be calculated as the proportion of randomized participants completing the 3- and 6-month follow-up assessments. For the proposed study, retention rates ≥80% over the 6-month intervention period would indicate the study is feasible as-is. If retention is \<80%, we will consider modifications to the study design and dedication of greater resources towards improving retention in the full-scale factorial trial.

    Time frame: 3 months, 6 months,

  2. Percentage of participants that adhered to the 10-week foundational support sessions

    Adherence to the 10-week foundational support sessions will be measured as the percentage of attended sessions relative to scheduled sessions. For the proposed study, the feasibility benchmark for adherence was set at ≥80% attendance. If adherence is \<80%, we will consider modifications to the study design and dedication of greater resources towards improving adherence in the full-scale factorial trial. The other measures of adherence will be evaluated with descriptive statistics. Completion rates of weekly logs for food intake, physical activity, and mind-based practices will be documented and tracked in REDCap. Additionally, daily usage of Garmin scales and fitness trackers will be monitored, with rates of adherence assessed as the percentage of days that participants engage with these devices.

    Time frame: 10 weeks

Secondary outcomes

  1. Overall Weight Loss Maintenance without medication

    Participants will be weighed at Baseline, 3 month, and 6 month intervals to see if they have maintained their overall weight loss.

    Time frame: Baseline, 3 months, 6 moths

07

Study locations

1 site
  • University of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
    • Holly Wyatt, MD · Contact · drholly@uab.edu · 205-975-6270
    • Holly Wyatt, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — At the time of publication(s) related to this trial, a fully de-identified dataset including participant data will be made available so that data analysis can be replicated by other investigators. This dataset will be freely available for download as supplemental materials to manuscripts(s) submitted to PubMed Central.

Supporting information: Study protocol, Sap, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07535892
Lead sponsor
University of Alabama at Birmingham
Collaborators
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Holly Wyatt (Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Apr 17, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Apr 30, 2029 (estimated)
Completion
Jul 31, 2029 (estimated)
Last update
Jun 26, 2026

Study contacts

Holly Wyatt, MD
Contact
drholly@uab.edu
303-378-6720
Holly Wyatt, MD
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion